POINT Biopharma Global Inc. Quarterly Assets in USD from Q2 2020 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: POINT Biopharma Global Inc. quarterly Assets history and growth rate from Q2 2020 to Q3 2023.
POINT Biopharma Global Inc. Assets for the quarter ending September 30, 2023 was $478M, a 46.7% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2023	$478M	+$152M	+46.7%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$498M	+$264M	+113%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$559M	+$306M	+121%	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$578M	+$315M	+120%	Dec 31, 2022	10-Q	2023-11-13
Q3 2022	$326M	+$48.5M	+17.5%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$234M	-$63.2M	-21.3%	Jun 30, 2022	10-Q	2022-08-12
Q1 2022	$253M	+$116M	+85.3%	Mar 31, 2022	10-Q	2022-05-13
Q4 2021	$263M	+$241M	+1086%	Dec 31, 2021	10-K	2023-03-27
Q3 2021	$277M	+$140M	+102%	Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$297M	+$297M	+57756%	Jun 30, 2021	10-Q	2021-08-13
Q1 2021	$136M			Mar 31, 2021	10-Q	2021-04-29
Q4 2020	$22.2M			Dec 31, 2020	10-K	2022-03-25
Q3 2020	$137M			Sep 30, 2020	10-Q	2020-11-02
Q2 2020	$514K^*			Jun 30, 2020	10-Q	2020-08-20

* An asterisk sign (*) next to the value indicates that the value is likely invalid.